Sitomni-M 50/500 — Sitagliptin Phosphate IP equivalent to Sitagliptin 50 mg and Metformin Hydrochloride IP 500 mg, with excipients q

Sitomni-M 50/500 is a pharmaceutical product manufactured and marketed by EMK Omni Pharma, a trusted pharmaceutical company based in Mysuru, Karnataka. It belongs to the Diabetes Care therapeutic category and is available as a Tablet formulation.

SITOMNI-M 50/500 by EMK Omni Pharma is a prescription medicine containing Sitagliptin 50 mg and Metformin Hydrochloride 500 mg in film coated tablet form. This combination may be prescribed by healthcare professionals for physician-guided diabetes management support, particularly in patients who require a doctor-supervised approach to blood sugar control. SITOMNI-M 50/500 Tablets by EMK Omni Pharma belong to the anti-diabetic pharmaceutical category and should be used only under medical supervision. The medicine contains Sitagliptin Phosphate equivalent to Sitagliptin and Metformin Hydrochloride, both widely used in prescription-based diabetes care. Patients should take this medicine only as advised by a registered medical practitioner and should not self-medicate or alter the dosage without professional guidance.

Each tablet of Sitomni-M 50/500 contains the following active pharmaceutical ingredients:

Active Composition: Sitagliptin Phosphate IP equivalent to Sitagliptin 50 mg and Metformin Hydrochloride IP 500 mg, with excipients q

Dosage Strength: 50 mg & 500 mg

Medicine Type: Tablet

Pack Size: 10 X 15 Tablets

The formulation is prepared with approved excipients to ensure optimal stability, bioavailability, and therapeutic efficacy. All ingredients comply with Indian Pharmacopoeia (IP) standards where applicable.

Sitomni-M 50/500 is classified under the Diabetes Care therapeutic category. This category encompasses medicines that are commonly prescribed by healthcare professionals for conditions related to type 2 diabetes management, blood sugar control, glycaemic management, insulin resistance, and metabolic health.

SITOMNI-M 50/500 by EMK Omni Pharma may be prescribed by doctors as part of a physician-guided diabetes management plan for patients who require a combination of Sitagliptin and Metformin Hydrochloride. In clinical practice, this type of prescription medicine may be considered when a healthcare professional decides that combination anti-diabetic therapy is suitable for the patient’s condition, medical history and ongoing blood sugar management needs. Patients should use SITOMNI-M 50/500 Tablets only under the supervision of a registered medical practitioner. They should not self-medicate, change the prescribed dosage, stop the medicine suddenly, combine it with other diabetes medicines, or use it with other prescriptions without consulting their doctor. Tablets should be taken only as advised by the physician and should not be crushed or chewed unless specifically instructed by a healthcare professional.

Sitomni-M 50/500 is formulated as a Tablet with a dosage strength of 50 mg & 500 mg. It is available in a pack size of 10 X 15 Tablets.

This product is designed for oral administration and should be taken exactly as prescribed by a registered medical practitioner. Patients should not alter the dosage, crush, chew, or break the tablet unless specifically instructed by their physician.

Important: The dosage and duration of treatment are determined by the prescribing physician based on the patient's individual medical condition, age, weight, and response to treatment.

Proper storage of pharmaceutical products is essential to maintain their quality, potency, and safety. Sitomni-M 50/500 should be stored according to the following guidelines:

Storage instructions mention that the product should be stored in a cool, dry and dark place below 25°C, protected from direct sunlight, heat and moisture.

General Storage Guidelines:

• Keep the medicine in its original packaging until use
• Do not use the medicine after the expiry date printed on the packaging
• Do not store in the bathroom or near a sink
• Protect from direct sunlight, heat, and humidity
• Keep out of reach of children and pets

Sitomni-M 50/500 is a prescription-based pharmaceutical product. It must only be dispensed and used under the guidance of a registered medical practitioner.

Prescription Warning: Schedule G Prescription Drug - Caution: It is dangerous to take this preparation except under medical supervision.

This medicine is regulated under Indian pharmaceutical laws and is subject to Schedule H / Schedule G drug regulations as applicable. It should not be purchased or used without a valid prescription from a licensed healthcare professional.

For Healthcare Professionals: Sitomni-M 50/500 is available through authorised pharmaceutical distribution channels. For product availability, pricing, and distribution enquiries, please contact EMK Omni Pharma directly.

Caution Details: The medicine should be kept out of reach of children.

General Safety Information:

• Do not self-medicate. Always consult a qualified healthcare professional before starting any new medication.
• Inform your doctor about all other medicines, supplements, or herbal products you are currently taking to avoid potential drug interactions.
• If you experience any unexpected side effects or adverse reactions, stop taking the medicine and consult your physician immediately.
• Do not share this medicine with others, even if they have similar symptoms.
• Follow the complete course of treatment as prescribed by your doctor.
• Pregnant or breastfeeding women should consult their physician before using this medicine.
• This medicine is not recommended for use in children unless specifically prescribed by a paediatrician.

EMK Omni Pharma is a trusted pharmaceutical company based in Mysuru, Karnataka, operating as Under the visionary leadership of Kumara Swamy, the company is committed to providing high-quality, physician-guided pharmaceutical products across multiple therapeutic areas.

Our product portfolio includes medicines for Cardiac Care, Cholesterol & Lipid Care, Blood Pressure Management, Nutritional Supplements, Pain Management, and Diabetes Care, all formulated to meet established pharmaceutical quality standards. EMK Omni Pharma works closely with healthcare professionals, pharmacies, hospitals, and distribution partners to ensure that quality medicines reach those who need them — safely, reliably, and responsibly.

Office Address: 2nd Floor, Room No. 01, 102A, Panchamantra Rd, above Kumar Medicals, Kuvempu Nagara, Mysuru, Karnataka 570023

Email: info@emkomnipharma.com

The information provided on this page is intended for general educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations.

This product information should not be used as a substitute for professional medical advice. Always consult a qualified and registered medical practitioner before starting, stopping, or changing any medication. Self-medication can be harmful and may lead to serious health consequences.

EMK Omni Pharma does not make any therapeutic claims about curing, treating, or preventing any disease without proper clinical evidence and regulatory approval. All products are intended for use only under proper medical supervision.

The product details, composition, and usage guidelines mentioned here are based on the manufacturer's product information and are subject to change. For the most current product information, please refer to the actual product packaging or consult your healthcare provider.